Viemed Healthcare, Inc. (VMD)
NASDAQ: VMD · Real-Time Price · USD
9.09
+0.24 (2.71%)
Aug 24, 2026, 4:00 PM EDT - Market closed
Viemed Healthcare Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 346 | 282 | 312 | 302 | 287 | 207 | |
Market Cap Growth | 30.11% | -9.54% | 3.35% | 5.12% | 39.02% | -31.94% |
Enterprise Value | 347 | 298 | 310 | 303 | 271 | 188 |
Last Close Price | 9.09 | 7.43 | 8.02 | 7.85 | 7.56 | 5.22 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.21 | 18.92 | 27.72 | 29.50 | 46.20 | 22.66 |
Forward PE | 18.30 | 16.89 | 19.33 | 21.22 | 34.36 | 18.89 |
PS Ratio | 1.15 | 1.05 | 1.39 | 1.65 | 2.07 | 1.77 |
PB Ratio | 2.40 | 1.97 | 2.34 | 2.65 | 2.96 | 2.18 |
P/TBV Ratio | 4.13 | 3.47 | 3.20 | 3.62 | 2.96 | 2.18 |
P/FCF Ratio | 11.84 | 23.68 | 236.93 | 15.80 | 59.26 | 75.16 |
P/OCF Ratio | 5.70 | 5.44 | 7.99 | 6.68 | 10.36 | 9.19 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.15 | 1.10 | 1.38 | 1.66 | 1.95 | 1.60 |
EV/EBITDA Ratio | 6.22 | 5.91 | 7.28 | 8.22 | 11.27 | 8.60 |
EV/EBIT Ratio | 13.59 | 13.65 | 17.97 | 20.23 | 32.24 | 17.83 |
EV/FCF Ratio | 11.87 | 24.97 | 235.22 | 15.85 | 55.82 | 68.24 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.08 | 0.11 | 0.05 | 0.09 | 0.01 | 0.07 |
Debt / EBITDA Ratio | 0.20 | 0.31 | 0.16 | 0.27 | 0.03 | 0.30 |
Debt / FCF Ratio | 0.40 | 1.34 | 5.21 | 0.54 | 0.14 | 2.44 |
Net Debt / Equity Ratio | 0.01 | 0.02 | -0.08 | -0.02 | -0.17 | -0.23 |
Net Debt / EBITDA Ratio | 0.02 | 0.05 | -0.25 | -0.07 | -0.67 | -0.99 |
Net Debt / FCF Ratio | 0.03 | 0.21 | -8.10 | -0.13 | -3.34 | -7.88 |
Asset Turnover | 1.55 | 1.44 | 1.35 | 1.35 | 1.18 | 1.02 |
Inventory Turnover | 26.75 | 24.52 | 20.35 | 17.12 | 17.96 | 18.31 |
Quick Ratio | 0.90 | 0.96 | 1.14 | 0.97 | 1.71 | 2.42 |
Current Ratio | 1.13 | 1.18 | 1.42 | 1.19 | 2.11 | 2.66 |
Return on Equity (ROE) | 10.45% | 11.11% | 9.23% | 9.71% | 6.48% | 10.34% |
Return on Assets (ROA) | 8.21% | 7.25% | 6.49% | 6.88% | 4.47% | 5.71% |
Return on Invested Capital (ROIC) | 12.27% | 11.48% | 10.40% | 11.09% | 7.55% | 11.35% |
Return on Capital Employed (ROCE) | 16.30% | 13.80% | 12.30% | 12.20% | 8.60% | 10.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.19% | 5.29% | 3.61% | 3.39% | 2.17% | 4.41% |
FCF Yield | 8.44% | 4.22% | 0.42% | 6.33% | 1.69% | 1.33% |
Buyback Yield / Dilution | 1.92% | -0.05% | -1.05% | -1.44% | 2.15% | -0.38% |